Stock Yearly Return 2015
Start date: 12/31/2014
End date: 12/31/2015
Start price/share: $38.00
End price/share: $750.00
Dividends collected/share: $0.00
Total return: 1,873.68%
Average Annual Total Return: 1,873.68%
Starting investment: $10,000.00
Ending investment: $197,368.00
Years: 1.00


AYTU average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare AYTU average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into AYTU


Also see:
AYTU stock yearly return 2016
AYTU stock yearly return 2017
AYTU stock yearly return 2018
AYTU stock yearly return 2019
AYTU stock yearly return 2020
AYTU YTD return
AYTU average annual return 10 years
AYTU BioPharma is a pharmaceutical company focused on commercializing products that address healthcare needs. Co.'s Primary Care Portfolio includes: Natesto®, which is a nasal formulation of testosterone for men with hypogonadism (low testosterone); ZolpiMist®, which is an oral spray prescription sleep aid; and Tuzistra® XR, which is a codeine-based antitussive syrup. Co.'s Pediatric Portfolio includes; Cefaclor, which is a cephalosporin antibiotic suspension; Karbinal® ER, which is an extended-release carbinoxamine (antihistamine) suspension indicated to treat various allergic conditions; and Poly-Vi-Flor® and Tri-Vi-Flor®, which are prescription fluoride-based supplement product lines. The AYTU stock yearly return is shown above.

The yearly return on the AYTU stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2015 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the AYTU annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for AYTU:
AYTU SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AYTU BioPharma (AYTU) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

AZN Average Annual Return
AZRX Average Annual Return
BABY Average Annual Return
BASI Average Annual Return
BAX Average Annual Return
BCLI Average Annual Return
BCRX Average Annual Return
BDSI Average Annual Return
BDX Average Annual Return
BEAT Average Annual Return
More Healthcare companies »

 

AYTU Stock Yearly Return 2015 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.